Literature DB >> 19272947

Optimal intervention strategies for cyclic therapeutic methods.

Golnaz Vahedi1, Babak Faryabi, Jean-Francois Chamberland, Aniruddha Datta, Edward R Dougherty.   

Abstract

External control of a genetic regulatory network is used for the purpose of avoiding undesirable states such as those associated with a disease. Certain types of cancer therapies, such as chemotherapy, are given in cycles with each treatment being followed by a recovery period. During the recovery period, the side effects tend to gradually subside. In this paper, it is shown how an optimal cyclic intervention strategy can be devised for any Markovian genetic regulatory network. The effectiveness of optimal cyclic therapies is demonstrated through numerical studies for random networks. Furthermore, an optimal cyclic policy is derived to control the behavior of a regulatory model of the mammalian cell-cycle network.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19272947     DOI: 10.1109/TBME.2008.2003092

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  4 in total

1.  Multi-objective optimal chemotherapy control model for cancer treatment.

Authors:  S Algoul; M S Alam; M A Hossain; M A A Majumder
Journal:  Med Biol Eng Comput       Date:  2010-10-01       Impact factor: 2.602

2.  Recent advances in intervention in markovian regulatory networks.

Authors:  Babak Faryabi; Golnaz Vahedi; Aniruddha Datta; Jean-Francois Chamberland; Edward R Dougherty
Journal:  Curr Genomics       Date:  2009-11       Impact factor: 2.236

3.  Newton, laplace, and the epistemology of systems biology.

Authors:  Michael L Bittner; Edward R Dougherty
Journal:  Cancer Inform       Date:  2012-10-30

Review 4.  Recent development and biomedical applications of probabilistic Boolean networks.

Authors:  Panuwat Trairatphisan; Andrzej Mizera; Jun Pang; Alexandru Adrian Tantar; Jochen Schneider; Thomas Sauter
Journal:  Cell Commun Signal       Date:  2013-07-01       Impact factor: 5.712

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.